Barbara-Jean Anne Bormann-Kennedy

Director, Xeris Biopharma Holdings, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$0.2M

Companies

Latest trade

Jun 4, 2026

Companies

Xeris Biopharma Holdings, Inc.Director −$0.2M

Trades

XERS Sold 16,000 shares at $6.09 · planned $0.1M Jun 4

XERS Sold 15,000 shares at $7.09 · planned $0.1M Dec 12

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.